We welcome Prof. Vodušek in his new role as chairman of the European Affairs sub-Committee (EAsC). He is already the extremely successful chair of EAN’s Liaison Committee and will in future also take care of the EAN-projects in Brussels. We are more than happy to have him also in this new position and thank him for his engagement.

Two events were organised by EBC for the 2017 Brain Awareness Week (BAW) 2017:

Report from Dr Jasur Toshev from Tashkent, Uzbekistan visiting Department of Neurology, Antwerp University Hospital, Edegem, Belgium under the supervision of Prof. Patrick Cras.

Please find below articles from Romanian authors that were published in the European Journal of Neurology.

Patient Organisation Profile

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

The meet and greet event will take place at the wonderful Hermitage Museum, a unique, historic building in the Center of Amsterdam. The Amstelhof, as the museum was called before, is one of the finest examples of monumental classicist architecture… Continue Reading

Marianne de Visser (MdV): Neuromuscular diseases are an important topic on our annual congresses, both in the Scientific and in the Educational Program. Therefore we would like to introduce the World Muscle Society of which you are the founding father to the EANpages readership. Can you please briefly illustrate the WMS and its goals to the readers of the EANpages? Victor Dubowitz (VD): In March 1995 I met up with Giovanni Nigro and Luciano Merlini in Bologna to discuss the formation of a new international society dedicated to neuromuscular diseases.

    By Agnita Boon, on behalf of the Dutch Society for Movement Disorders       This task force on Movement Disorders of the Dutch Association of Neurology was founded in 2006. The board consist of representatives with special… Continue Reading

The revision of the International Classification of Diseases (ICD) is a highly complicated process handled by experts in statistics at the WHO in Geneva. The influence of Neurological Societies onto the creation of a revision is through the accredited Societies which are for Neurology and Stroke the World Federation of Neurology (WFN) and the World Stroke Organisation (WSO). They are working within the Topic Advisory Group Neurology (TAGN) and can only make recommendations to the experts. April 2011 the TAGN advised to shift the section “Cerebrovascular diseases” covering all types of stroke from the “Diseases of the circulatory system” class (as it is in ICD-10) into the “Diseases of the nervous system” class (as it proposed in the draft ICD-11). This corresponds to a change of the statistical and legal placement of stroke from Internal Medicine to Neurology. This was then executed accordingly 5 years ago and stroke went under the neurological diseases (08) in the beta-version of the ICD-11. Neurologists all over the world agreed with this decision.

or May 2017 we have selected: Kermer P, Eschenfelder CC, Diener H-C, et al.  Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection. International Journal of Stroke 2017; doi: 10.1177/1747493017701944. The use of non-vitamin-K-antagonist oral anticoagulants (NOACs) to prevent stroke in patients with atrial fibrillation is increasing worldwide.